|
rs16947
|
CYP2D6
*2
|
Common CYP2D6 variant defining the *2 allele; previously considered normal-fu...
|
Pharmacogenomics
|
|
Strong
|
|
rs6511720
|
LDLR
Intron 1
|
Common regulatory variant in the LDL receptor gene affecting LDLR expression,...
|
Heart & Inflammation
|
|
Strong
|
|
rs25531
|
SLC6A4
A>G
|
Promoter SNP near 5-HTTLPR that modifies serotonin transporter expression and...
|
Brain & Mental Health
|
|
Moderate
|
|
rs5030655
|
CYP2D6
*6
|
Frameshift deletion causing no enzyme function, defining poor metabolizer sta...
|
Pharmacogenomics
|
|
Established
|
|
rs28371725
|
CYP2D6
*41
|
Intronic splice variant causing decreased CYP2D6 enzyme activity through aber...
|
Pharmacogenomics
|
|
Established
|
|
rs776746
|
CYP3A5
*3
|
Splice site variant creating a non-functional CYP3A5 enzyme, dramatically aff...
|
Pharmacogenomics
|
|
Established
|
|
rs3918290
|
DPYD
*2A
|
Most critical pharmacogenomic variant causing complete loss of DPD enzyme fun...
|
Pharmacogenomics
|
|
Established
|
|
rs67376798
|
DPYD
D949V
|
Decreased-function variant reducing DPD enzyme activity ~30%, requiring 50% f...
|
Pharmacogenomics
|
|
Established
|
|
rs1142345
|
TPMT
*3C
|
No-function variant causing deficient thiopurine methylation; most common TPM...
|
Pharmacogenomics
|
|
Established
|
|
rs1799971
|
OPRM1
A118G
|
Mu-opioid receptor variant affecting opioid response, pain sensitivity, and p...
|
Pharmacogenomics
|
|
Moderate
|
|
rs1045642
|
ABCB1
C3435T
|
Synonymous variant in P-glycoprotein affecting drug efflux pump expression an...
|
Pharmacogenomics
|
|
Moderate
|
|
rs4148323
|
UGT1A1
*6 Gly71Arg
|
Phase II glucuronidation enzyme that metabolizes bilirubin and many drugs inc...
|
Pharmacogenomics
|
|
Established
|
|
rs2740574
|
CYP3A4
*1B -392A>G
|
Promoter variant affecting CYP3A4 expression, most common in African populations
|
Pharmacogenomics
|
|
Moderate
|
|
rs116855232
|
NUDT15
Arg139Cys
|
Nucleotide diphosphatase that inactivates toxic thiopurine metabolites; reduc...
|
Pharmacogenomics
|
|
Established
|
|
rs5219
|
KCNJ11
E23K
|
Controls the pancreatic beta-cell potassium channel that regulates insulin se...
|
Nutrition & Metabolism
|
|
Strong
|